Scientific Program

Day I
26th August 2017
9:45 - 10.00am Introductions and Welcome BM Makkar  
10.00 - 11.15am SESSION 1   V Mohan
R Chawla
  Glucagon revisited Adi Mehta  
  Pathobiology of Diabetes Complications Melissa Li - Ng  
  Insulin Therapy in 2020 Mario Skugor  
11.15 - 11.45am Plenary - Personalised Diabetes Care - Are we there yet? V Mohan S Banerjee
Meena Chhabra
11.45 - 12.00pm TEA BREAK    
12:00 - 1.15pm SESSION 2   Jayant Panda
  Looking beyond Glycaemic Control - Addressing Cardiac Protection Melissa Li - Ng  
  Looking beyond Glycaemic Control - Addressing Renal Protection M Skugor  
  Diabetes Drugs for the Renal Compromised Patient C Faiman  
1.15 - 2.15pm LUNCH BREAK    
2.15 - 2.45pm Debate - Weight Gain is An Over - Hyped Adverse Effect of Diabetes Treatments For - Adi Mehta
Against - M Skugor
Krishna Kumar
Sanjay Agarwal
2.45 - 4.00pm SESSION 3 -    
  Old Problems, New Solutions— Insulin Management through Innovations Adi Mehta DK Hazra
Rakesh Gupta
  Closed loop pump technology M Skugor  
  Prevention of Diabetes 20+5 V Mohan  
4.00 - 4.30pm TEA BREAK    
4.30 - 5.45pm SESSION 4   RK Marya
AK Jhingan
  Stress Hyperglycaemia Adi Mehta  
  Male hypogonadism C Faiman  
  Type 2 Diabetes and Thyroid Disorders - What and How to look for? Mario Skugor  
5.45 - 6.15pm DEBATE - Hypoglycaemia Is An Over - Hyped Complication of Sulfonylureas For - C Faiman
Against - Adi Mehta
Manoj Chawla
RK Lalwani
6.15 - 7.00pm Case Studies BM Makkar Cle Faculty
Rajeev Chawla
AK Singh
7.00pm onwards Dinner and Fellowship    
Day II
27th August 2017
9.00 - 10:15am SESSION 5 - TREATMENT STRATEGIES   Arvind Gupta
Girish Khurana
  Conventional Therapies for T2DM - MET+SU - Where do we stand? BM Makkar  
  Newer Therapies - GLP1 RA, Gliptins, SGLT2s - Are they making a difference in achieving glycaemic goals Melissa Li - Ng  
  Next Generation of Therapies for Type 2 Diabetes C Faiman  
10:15 - 10.45am Plenary - LDL Particles and CV Risk - Matter of Size, or Number? Adi Mehta JK Sharma
S Sengupta
10.45 - 11.15am TEA BREAK    
11.15 - 12.30pm SESSION 6 -   Shalini Jaggi
Sanjay Reddy
  Managing HTN in Diabetes - Do newer agents(azilsartan, cilnidipine) offer any advantage? S Joshi  
  Do we need to test fasting blood samples for managing diabetes? BM Makkar  
  The New ADA Consensus Guidelines on Diabetic Peripheral Neuropathy—Will They Change Your Practice/Management? Mario Skugor  
12.30 - 1.00pm Recent Advances - Snapshot ADA 2017
23mins+7mins discussion
Shashank Joshi Vinod Mittal
2.00 - 3.30pm SESSION - CVOTs   AK Singh
Rajeev Kovil
  Gliptin CVOTs - What did they tell us? Adi Mehta  
  GLP 1RA CVOTs - Where do we stand? Anil Bhansali  
  CANVAS - Cana Proves the Point. Mario Skugor  
  CVD Real Melissa Li - Ng  
  DEVOTE Melissa Li - Ng  
  Cardiovascular Outcomes Trials - Do these make sense...or dollars? C Faiman  
4.30 - 4.45pm Closing Remarks and Feedback    
4.45pm TEA    


26th August 2017 - Workshops 1&2

11.45am - 01.15pm
Clinical Decision Making based on RSSDI Clinical Practice Guidelines for Indians
Rajeev Chawla, Banshi Saboo

03.00pm - 04.30pm
Technologies in Diabetes Management
Jothydev, Manoj Chawla
Attendance to workshops by prior registration, limited to 75 delegates on first come first serve basis.

27th August 2017 - Workshops 3&4

10.00am - 11.15am
Insulin Initiation, Intensification and Optimisation in Clinical Practice
Banshi Saboo, Rajeev Kovil, BM Makkar

11.30am - 12.45pm
Workshop on DEVOTE Trial
A. K. Singh, Rajeev Chawla
Attendance to workshops by prior registration, limited to 75 delegates on first come first serve basis.

Please Contact

Dr. B. M. Makkar
Diabetes and Obesity Centre
A – 5B/122, Paschim Vihar, New Delhi – 110 063
Tel: +91-11-2526 7671 / 2528 0150
Fax: +91-11-4568 3367
Mobile: +91-98-110-77419

Connect with us

Official Conference Manager

CIMGlobal India Pvt. Ltd.
Suite No. 309-311, DLF City Court,
MG Road Gurgaon 122 004, Haryana, India
Pratibha Verma
Mob: +91 73513 01122

© CCACCD.COM All rights reserved.